These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24661573)

  • 1. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
    de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
    Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary cutaneous melanoma arising in agminated melanocytic nevi: CDKN2A and CDK4 mutation screening.
    Rezze GG; Leon A; Silva DC; Neves RI; Molina GC; Carraro DM; Landman G; Duprat JP
    Acta Derm Venereol; 2012 Jan; 92(1):98-9. PubMed ID: 21710107
    [No Abstract]   [Full Text] [Related]  

  • 3. Melanocytic nevi and melanoma: unraveling a complex relationship.
    Damsky WE; Bosenberg M
    Oncogene; 2017 Oct; 36(42):5771-5792. PubMed ID: 28604751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma.
    Dong J; Phelps RG; Qiao R; Yao S; Benard O; Ronai Z; Aaronson SA
    Cancer Res; 2003 Jul; 63(14):3883-5. PubMed ID: 12873977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study.
    von Roenn JH; Kheir SM; Wolter JM; Coon JS
    Cancer Res; 1986 Jun; 46(6):3192-5. PubMed ID: 3698035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 7. Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.
    Barnhill RL
    Dermatology; 1993; 187(2):86-90. PubMed ID: 8358111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine model for the development of melanocytic nevi and their progression to melanoma.
    Nasti TH; Cochran JB; Tsuruta Y; Yusuf N; McKay KM; Athar M; Timares L; Elmets CA
    Mol Carcinog; 2016 May; 55(5):646-58. PubMed ID: 25788145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A search for CDKN2A/p16INK4a mutations in melanocytic nevi from patients with melanoma and spouse controls by use of laser-captured microdissection.
    Wang H; Presland RB; Piepkorn M
    Arch Dermatol; 2005 Feb; 141(2):177-80. PubMed ID: 15724013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.
    Bauer J; Bastian BC
    Dermatol Ther; 2006; 19(1):40-9. PubMed ID: 16405569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classifying melanocytic tumors based on DNA copy number changes.
    Bastian BC; Olshen AB; LeBoit PE; Pinkel D
    Am J Pathol; 2003 Nov; 163(5):1765-70. PubMed ID: 14578177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
    Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
    Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.
    Masaki T; Wang Y; DiGiovanna JJ; Khan SG; Raffeld M; Beltaifa S; Hornyak TJ; Darling TN; Lee CC; Kraemer KH
    Pigment Cell Melanoma Res; 2014 May; 27(3):454-64. PubMed ID: 24483290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolutionary processes of melanomas from giant congenital melanocytic nevi.
    Lim Y; Shin HT; Choi Y; Lee DY
    Pigment Cell Melanoma Res; 2020 Mar; 33(2):318-325. PubMed ID: 31584755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
    Yasuda H
    Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention.
    Rhodes AR
    Ann Intern Med; 1985 Apr; 102(4):546-8. PubMed ID: 3977199
    [No Abstract]   [Full Text] [Related]  

  • 17. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin.
    Uribe P; Wistuba II; González S
    Am J Dermatopathol; 2003 Oct; 25(5):365-70. PubMed ID: 14501284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic alterations in melanocytic tumors.
    Takata M; Saida T
    J Dermatol Sci; 2006 Jul; 43(1):1-10. PubMed ID: 16750612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genetic Evolution of Melanoma from Precursor Lesions.
    Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
    N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.